Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.

Daniel C BeachlerGail FernandesGaurav DeshpandeJamileh JemisonJennifer G LyonsStephan LanesJinan LiuAnnie McNeill

Published in: Current medical research and opinion (2018)

Roughly half of commercially-insured T2DM patients discontinued SU within 1 year after insulin initiation, and SU discontinuation was not strongly associated with a range of patient and provider characteristics.

Keyphrases

type diabetes
end stage renal disease
case report
glycemic control
ejection fraction
newly diagnosed
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
electronic health record
emergency department
big data
adipose tissue
patient reported outcomes
patient reported